Camptothecin drugs are stabilized in their antitumor active lactone
form by complexation with an oligonucleotide including RNA or catalytic RNA. The
oligonucleotide-camptothecin drug complex may be incorporated within a macromolecular
assembly including both viral and non-viral oligonucleotide vectors. The invention
allows combination gene and camptothecin drug therapy.
